Striatal dopamine D-1 receptor binding was investigated in vivo with positron emission tomography (PET) in five patients with early Parkinson's disease using ["CI-SCH 23390. All patients had predominantly unilateral symptoms and showed a significant reduction in the accumulation of ["F]-6-F-DOPA in
PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease
✍ Scribed by Dr. J. O. Rinne; A. Laihinen; U. K. Rinne; K. Någren; J. Bergman; U. Ruotsalainen
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 715 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
[^11^C] Raclopride uptake to dopamine D~2~ receptors was investigated with positron emission tomography (PET) in patients with early Parkinson's disease at the time of the diagnosis and after a half‐year interval. During this progressive period of the disease, the patients received no antiparkinsonian medication. The upregulation of striatal D~2~ receptors, which was seen in all patients already at the time of the diagnosis, persisted. Although the patients initially showed unilateral disease, they had developed bilateral symptoms by the time of the second PET scan, but the disease was still asymmetric. The present results show that the relative increase in [^11^C]raclopride uptake in the striatum contralateral to the symptoms as compared with the opposite striatum will be preserved even during the progression of the disease, provided that the symptoms show clear‐cut asymmetry.
📜 SIMILAR VOLUMES
## Abstract We used [^11^C]raclopride (RACLO) and positron emission tomography (PET) to study longitudinally striatal dopamine D~2~ receptor binding in nine patients with Parkinson's disease (PD) at an early drug‐naive stage and 3–5 years later, when motor fluctuations had appeared in seven of them
The time course of the loss in presynaptic dopamine transporters (DAT) and of the increase in postsynaptic dopamine D2 receptors (D2R) was studied in a rat model of Parkinson's disease. For this, in vitro autoradiographic experiments were performed in the striatum using (E)-N-(3-iodoprop-2-enyl)-2be
The eect of acute oral ethanol intake (1 . 0 g/kg) on cerebral D2-receptors ([ 11 C]raclopride binding) was studied in seven healthy volunteers, using water and alcohol in two separate 59-min PET sessions. In the alcohol experiments, the blood ethanol concentration at the beginning of the imaging wa
## Abstract Striatal dopamine D~2~ receptor binding was studied in vivo with positron emission tomography in seven patients with early Parkinson's disease using [^11^C]–raclopride. The patients had unilateral symptoms and none of them had received levodopa treatment. The accumulation of [^11^C]–rac